STD Diagnostics Market Size, Share & Trends Analysis Report By Product (Instruments and Services, Consumables), By Application (HIV Testing, HSV Testing, Chlamydia Testing), By Technology, By Location Of Testing, By Region, And Segment Forecasts, 2024 - 2030

Research Methodology

A three-pronged approach was followed for deducing the std diagnostics Market market estimates and forecasts. The process has three steps: information procurement, analysis, and validation. The whole process is cyclical, and steps repeat until the estimates are validated. The three steps are explained in detail below:

Information procurement: Information procurement is one of the most extensive and important stages in our research process, and quality data is critical for accurate analysis. We followed a multi-channel data collection process for std diagnostics Market market to gather the most reliable and current information possible.

• We buy access to paid databases such as Hoover’s and Factiva for company financials, industry information, white papers, industry journals, SME journals, and more.
• We tap into Grand View’s proprietary database of data points and insights from active and archived monitoring and reporting.
• We conduct primary research with industry experts through questionnaires and one-on-one phone interviews.
• We pull from reliable secondary sources such as white papers and government statistics, published by organizations like WHO, NGOs, World Bank, etc., Key Opinion Leaders (KoL) publications, company filings, investor documents, and more.
• We purchase and review investor analyst reports, broker reports, academic commentary, government quotes, and wealth management publications for insightful third-party perspectives.

Analysis: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilized different methods of std diagnostics Market market data depending on the type of information we’re trying to uncover in our research.

• Market Research Efforts: Bottom-up Approach for estimating and forecasting demand size and opportunity, top-down Approach for new product forecasting and penetration, and combined approach of both Bottom-up and Top-down for full coverage analysis.

• Value-Chain-Based Sizing & Forecasting: Supply-side estimates for understanding potential revenue through competitive benchmarking, forecasting, and penetration modeling.

• Demand-side estimates for identifying parent and ancillary markets, segment modeling, and heuristic forecasting.

• Qualitative Functional Deployment (QFD) Modelling for market share assessment.

Market formulation and validation: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilize different methods of data analysis depending on the type of information we’re trying to uncover in our research.

• Market Formulation: This step involves the finalization of market numbers. This step on an internal level is designed to manage outputs from the Data Analysis step.

• Data Normalization: The final market estimates and forecasts are then aligned and sent to industry experts, in-panel quality control managers for validation.

• This step also entails the finalization of the report scope and data representation pattern.

• Validation: The process entails multiple levels of validation. All these steps run in parallel, and the study is forwarded for publishing only if all three levels render validated results.

STD Diagnostics Market Categorization:

The std diagnostics Market market was categorized into four segments, namely product (Instruments and Services, Consumables, Software), application (CT/NG testing, Syphilis testing, Gonorrhea testing, HSV testing, HPV testing, HIV testing, Ureaplasma & Mycoplasma testing, VZV testing,), technology (Immunoassay, Molecular Diagnostics), location of testing (Laboratory Testing, Point of Care Testing), and regions (North America, Europe, Asia Pacific, Latin America, Middle East & Africa).

Segment Market Methodology:

The std diagnostics Market market was segmented into product, application, technology, location of testing, and regions. The demand at a segment level was deduced using a funnel method. Concepts like the TAM, SAM, SOM, etc., were put into practice to understand the demand. We at GVR deploy three methods to deduce market estimates and determine forecasts. These methods are explained below:

Market research approaches: Bottom-up

• Demand estimation of each product across countries/regions summed up to from the total market.

• Variable analysis for demand forecast.

• Demand estimation via analyzing paid database, and company financials either via annual reports or paid database.

• Primary interviews for data revalidation and insight collection.

Market research approaches: Top-down

• Used extensively for new product forecasting or analyzing penetration levels.

• Tool used invoice product flow and penetration models Use of regression multi-variant analysis for forecasting Involves extensive use of paid and public databases.

• Primary interviews and vendor-based primary research for variable impact analysis.

Market research approaches: Combined

• This is the most common method. We apply concepts from both the top-down and bottom-up approaches to arrive at a viable conclusion.

Regional Market Methodology:

The std diagnostics Market market was analyzed at a regional level. The globe was divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, keeping in focus variables like consumption patterns, export-import regulations, consumer expectations, etc. These regions were further divided into twenty-three countries, namely, the U.S.; Canada; Germany; UK; France; Italy; Spain; Denmark; Sweden; Norway;China; Japan; India; Australia; South Korea; Thailand; Brazil; Mexico; Argentina;South Africa; Saudi Arabia; UAE; Kuwait

All three above-mentioned market research methodologies were applied to arrive at regional-level conclusions. The regions were then summed up to form the global market.

STD diagnostics market companies & financials:

The std diagnostics Market market was analyzed via companies operating in the sector. Analyzing these companies and cross-referencing them to the demand equation helped us validate our assumptions and conclusions. Key market players analyzed include:

• BD D, an American medical technology company, serves clinical laboratories, life sciences researchers, healthcare institutions, and the general public. The company manufactures and markets a wide range of devices, diagnostic products, medical supplies, and laboratory equipment. BD operates through three business segments: BD Diagnostics, BD Medical, and BD Biosciences. BD Diagnostics provides products for the safe collection and transportation of diagnostic specimens, as well as reagent systems and instruments that accurately detect a broad range of infections, infectious diseases, and cancer. The diagnostic systems offer fully automated molecular systems that provide rapid results, have less hands-on time, and are easy to use. The company has offices in around 50 countries. 

• F. Hoffmann-La Roche Ltd. F. Hoffmann-La Roche Ltd., a Swiss healthcare company, operates in two divisions: pharmaceuticals and diagnostics. The diagnostics division includes Roche Professional Diagnostics, Roche Molecular Diagnostics, Roche Tissue Diagnostics, and Roche Diabetes Care. The company's diagnostic products include blood glucose meters, point-of-care testing devices, high-throughput analyzers for commercial and hospital diagnostic laboratories, and reagents and instruments for life sciences research. Roche Molecular Diagnostics focuses on developing, manufacturing, and distributing tests based on PCR technology and medical diagnostic products, platforms, and services. The company caters to a number of clients, including physicians, researchers, laboratories, hospitals, patients, and blood banks. Roche employs over 98,000 people globally. 

• Hologic Inc. (Gen Probe) Hologic Incorporated, a global leader in women's health, is the parent company of Gen-Probe Incorporated, a molecular diagnostics company. Gen-Probe, now a wholly-owned subsidiary of Hologic, is headquartered in San Diego and is engaged in the development, manufacturing, and marketing of molecular diagnostic products and services. The company's products and services are primarily used for ensuring transplant compatibility, blood screening, and diagnosing human diseases. Gen-Probe has formed strategic alliances with several companies, including Novartis AG, DiagnoCure, F. Hoffmann-La Roche Ltd., Stratec Biomedical Systems AG, Roka Bioscience, Inc., and Life Technologies Corporation (LTC) to gain access to new markets, products, and technologies. Hologic, the parent company, is a leading developer, manufacturer, and supplier of premium diagnostic products, medical imaging systems, and surgical products. The company operates four core business units focused on breast health, diagnostics, GYN surgical, and skeletal health. Hologic employs over 6,478 people globally and is committed to breakthrough diagnostic and medical imaging solutions.

• Abbott Abbott, a global healthcare company, operates in four core business segments: pharmaceuticals, devices, nutrition, and diagnostics. The company has a significant presence in over 150 countries, with research, manufacturing, sales, and distribution facilities. Abbott's pharmaceuticals segment offers generic medicines for various conditions, while its diagnostics segment provides a wide range of products and services, including reagents and tests for various applications. The company's diagnostics portfolio includes technologies such as polymerase chain reaction, fluorescence in situ hybridization, and DNA & RNA sequencing. Abbott's immunoassays and clinical chemistry assays are used in the diagnosis of cancer, infectious diseases, cardiovascular diseases, fertility, and therapeutic drug monitoring. The company employs over 107,000 people globally. 

• Cepheid (Danaher) Cepheid, a wholly owned subsidiary of Danaher Corporation, is a molecular diagnostics company that develops, manufactures, and markets molecular systems and tests. The company's solutions automate time-consuming and complex manual procedures, offering institutions the ability to perform testing for genetic-based diseases and organisms. Cepheid focuses on applications where rapid, actionable, and accurate test results are required, such as infectious diseases and cancer. The company's product portfolio includes reagents, tests, and systems for clinical and non-clinical markets. Cepheid's GeneXpert system is a market leader in sample-to-answer PCR diagnostic testing, providing healthcare professionals with a best-in-class test menu for any setting. The company's solutions are known for delivering speed, accuracy, and flexibility, and its tests can be used to identify and analyze pathogens and genetic disorders. 

• QIAGEN QIAGEN, a German-founded multinational provider of sample and assay technologies for molecular applied testing, academic and pharmaceutical research, was established in 1984 and is headquartered in Venlo, The Netherlands. The company serves more than 500,000 customers around the globe, all seeking answers from the building blocks of life – DNA, RNA and proteins. QIAGEN provides samples and assay technologies for academic research, applied testing, molecular diagnostics, and pharmaceutical research. The company markets over 500 products including consumable kits and automation systems. QIAGEN products for molecular diagnostics cover the relevant areas of healthcare ranging from early diagnosis of diseases, establishment of diagnosis, diagnostic testing for determination of suitable treatment, and point-of-need testing. The company’s customers include healthcare providers, pharmaceutical & biotechnology companies, government or industrial customers, and researchers. It employs over 5200 people globally. 

• OraSure Technologies, Inc OraSure Technologies, Inc., a U.S.-based company, was incorporated in 1987 and is headquartered in the U.S. The company is engaged in manufacturing, developing, and distributing oral fluid diagnostic, and other technologies implemented to diagnose or detect severe medical conditions. OraSure Technologies focuses on manufacturing and selling various cryosurgical products for the removal of plantar warts and skin lesions. Its products are sold to clinics, hospitals, community-based organizations, and other public health organizations. In addition, via its wholly owned subsidiary DNA Genotek, Inc., the company also focuses on areas such as molecular diagnostics, oral fluid collector, and stabilizer. OraSure Technologies has around 472 employees globally.

• Bio-Rad Laboratories, Inc. Bio-Rad Laboratories, Inc., established in 1952 and headquartered in the U.S., is a leading manufacturer of systems and products used in separating complex biological and chemical materials and analyzing, identifying, and purifying their respective components. The company operates in two segments—clinical diagnostics and life sciences. In the clinical diagnostics segment, Bio-Rad designs, manufactures, supports, and sells informatics systems, test systems, quality controls, and test kits, serving clinical laboratories in the global market. Similarly, the life sciences segment involves the creation and discovery of tools required in biological processes. The company manufactures reagents, apparatus, and laboratory instruments used in the process of biopharmaceutical production, research techniques, and food testing regimes. Bio-Rad products are used by hospitals, research institutions, laboratories, biotechnology companies, and pharmaceutical firms. The company has direct distribution channels in approximately 35 countries. It employs 8250 people globally.

• bioMérieux SA bioMérieux SA, a French multinational biotechnology company, was founded in 1963 and is headquartered in Marcy-l'Étoile, France, close to Lyon. The company is a world leader in the field of in vitro diagnostics and has contributed greatly to improving public health worldwide. bioMérieux is present in over 160 countries and serves more than 160 countries with over 90% of international sales. The company has 18 production sites and 18 R&D sites. It employs 12,800 people globally. 

• Thermo Fisher Scientific, Inc. Thermo Fisher Scientific, Inc., an American company incorporated in 1956 and headquartered in Waltham, Massachusetts, is a leading manufacturer and supplier of scientific equipment, analytical instruments, and laboratory equipment globally. The company's operations are divided into pharmaceutical & biotechnology, industrial & applied research, diagnostics & healthcare, and academic & government. Thermo Fisher Scientific provides chromatographs, Erlenmeyer flasks, gene sequencers, spectrometers, clinical analytical tools, and diagnostic testing products. The company serves more than 400,000 customers globally through its brands—Applied Biosystem, Fisher Scientific, Thermo Scientific, Unity Lab Services, and Invitrogen. Its major products include molecular biology reagents, instruments, antibodies, protein biology reagents, and cell imaging & analysis instruments. Thermo Fisher Scientific employs over 75,000 people globally.

Value chain-based sizing & forecasting

Supply Side Estimates

• Company revenue estimation via referring to annual reports, investor presentations, and Hoover’s.

• Segment revenue determination via variable analysis and penetration modeling.

• Competitive benchmarking to identify market leaders and their collective revenue shares.

• Forecasting via analyzing commercialization rates, pipelines, market initiatives, distribution networks, etc.

Demand side estimates

• Identifying parent markets and ancillary markets

• Segment penetration analysis to obtain pertinent

• revenue/volume

• Heuristic forecasting with the help of subject matter experts

• Forecasting via variable analysis

STD Diagnostics Market Report Objectives:

• Understanding market dynamics (in terms of drivers, restraints, & opportunities) in the countries.

• Understanding trends & variables in the individual countries & their impact on growth and using analytical tools to provide high-level insights into the market dynamics and the associated growth pattern.

• Understanding market estimates and forecasts (with the base year as 2023, historic information from 2018 - 2022, and forecast from 2024 to 2030). Regional estimates & forecasts for each category are available and are summed up to form the global market estimates.

STD Diagnostics Market Report Assumptions:

• The report provides market value for the base year 2023 and a yearly forecast till 2030 in terms of revenue/volume or both. The market for each of the segment outlooks has been provided on region & country basis for the above-mentioned forecast period.

• The key industry dynamics, major technological trends, and application markets are evaluated to understand their impact on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis.

• We have used the bottom-up approach for market sizing, analyzing key regional markets, dynamics, & trends for various products and end-users. The total market has been estimated by integrating the country markets.

• All market estimates and forecasts have been validated through primary interviews with the key industry participants.

• Inflation has not been accounted for to estimate and forecast the market.

• Numbers may not add up due to rounding off.

• Europe consists of EU-8, Central & Eastern Europe, along with the Commonwealth of Independent States (CIS).

• Asia Pacific includes South Asia, East Asia, Southeast Asia, and Oceania (Australia & New Zealand).

• Latin America includes Central American countries and the South American continent

• Middle East includes Western Asia (as assigned by the UN Statistics Division) and the African continent.

Primary Research

GVR strives to procure the latest and unique information for reports directly from industry experts, which gives it a competitive edge. Quality is of utmost importance to us, therefore every year we focus on increasing our experts’ panel. Primary interviews are one of the critical steps in identifying recent market trends and scenarios. This process enables us to justify and validate our market estimates and forecasts to our clients. With more than 8,000 reports in our database, we have connected with some key opinion leaders across various domains, including healthcare, technology, consumer goods, and the chemical sector. Our process starts with identifying the right platform for a particular type of report, i.e., emails, LinkedIn, seminars, or telephonic conversation, as every report is unique and requires a differentiated approach.

We send out questionnaires to different experts from various regions/ countries, which is dependent on the following factors:

• Report/Market scope: If the market study is global, we send questionnaires to industry experts across various regions, including North America, Europe, Asia Pacific, Latin America, and MEA.

• Market Penetration: If the market is driven by technological advancements, population density, disease prevalence, or other factors, we identify experts and send out questionnaires based on region or country dominance.

The time to start receiving responses from industry experts varies based on how niche or well-penetrated the market is. Our reports include a detailed chapter on the KoL opinion section, which helps our clients understand the perspective of experts already in the market space.